Daclizumab Product Approval Information - Licensing Action

Proper name: Daclizumab
Tradename: Zenapax
Manufacturer: Hoffman-La Roche Inc, Nutley, NJ, License #0136
Revised Package Insert: Include pediatric use and update the Clinical Pharmacology, Clinical Studies, and Adverse Reactions sections of the package insert with three year posttransplant data
Approval Date: 7/29/2002
Type of submission: Biologics license application supplement


Approval Letter (PDF)

Label (PDF)

Page Last Updated: 10/04/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English